home / stock / phvs / phvs short
Short Information | Pharvaris N.V. (NASDAQ:PHVS)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 129,430 |
Total Actual Volume | 1,074,407 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 6,472 |
Average Short Percentage | 11.53% |
Is there a PHVS Short Squeeze or Breakout about to happen?
See the PHVS Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-17-2024 | $21.7 | $20.35 | $21.7 | $19.53 | 33,049 | 2,904 | 8.79% |
05-16-2024 | $22.1 | $21.71 | $24.11 | $21.36 | 14,213 | 1,500 | 10.55% |
05-15-2024 | $21.1 | $22.1 | $23.07 | $21.1 | 60,954 | 10,864 | 17.82% |
05-14-2024 | $21.56 | $20.8 | $21.56 | $20.7 | 17,452 | 1,111 | 6.37% |
05-13-2024 | $21.68 | $21.17 | $22.135 | $20.75 | 22,529 | 2,720 | 12.07% |
05-10-2024 | $20.79 | $21.46 | $21.52 | $20.14 | 66,628 | 7,470 | 11.21% |
05-09-2024 | $20.72 | $20.57 | $20.86 | $20.33 | 23,166 | 4,158 | 17.95% |
05-08-2024 | $22.36 | $20.85 | $22.575 | $20.59 | 27,497 | 1,609 | 5.85% |
05-07-2024 | $22.59 | $22.62 | $23.13 | $21.69 | 45,524 | 5,099 | 11.2% |
05-06-2024 | $22.95 | $22.68 | $24.02 | $21.875 | 56,526 | 10,300 | 18.22% |
05-03-2024 | $23.77 | $22.6 | $23.9 | $22.475 | 55,488 | 3,176 | 5.72% |
05-02-2024 | $24.685 | $23.53 | $25.5 | $23.49 | 78,777 | 17,202 | 21.84% |
05-01-2024 | $24.01 | $24.57 | $25.16 | $23.16 | 114,135 | 7,195 | 6.3% |
04-30-2024 | $23.25 | $24.59 | $25.2 | $23.25 | 67,926 | 6,157 | 9.06% |
04-29-2024 | $23.35 | $23.45 | $24.15 | $22.55 | 49,577 | 3,508 | 7.08% |
04-26-2024 | $22.56 | $23.35 | $25.44 | $22.2 | 85,067 | 15,627 | 18.37% |
04-25-2024 | $20.74 | $22.77 | $24 | $19.59 | 82,367 | 6,173 | 7.49% |
04-24-2024 | $21.45 | $21.25 | $22.715 | $21.02 | 34,153 | 2,501 | 7.32% |
04-23-2024 | $20.85 | $21.29 | $24.2 | $20.54 | 88,778 | 14,580 | 16.42% |
04-22-2024 | $19.5 | $20.87 | $20.87 | $17.57 | 50,601 | 5,576 | 11.02% |
News, Short Squeeze, Breakout and More Instantly...
Pharvaris N.V. Company Name:
PHVS Stock Symbol:
NASDAQ Market:
ZUG, Switzerland, May 13, 2024 (GLOBE NEWSWIRE) -- Pharvaris (NASDAQ:PHVS), a late-stage biopharmaceutical company developing novel, oral bradyk...
ZUG, Switzerland, May 13, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, today announced the acceptance of abstracts for presentation ...
RAPIDe-3, a global pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, currently enrolling End-of-Phase 2 meeting scheduled to discuss development plan of deucrictibant for the prophylaxis of HAE attacks Executing from a strong financial position with cash a...